HIV-1 infection and central monoamine neurotransmitters

American Journal of Infectious Diseases

Volumn 3, Issue 4, 2007, Pages 177-183

  Kumar, Adarsh M ^a   Fernandez, J B ^a   Borodowsky, Irina ^a   Gonzalez, Louis ^a   Kumar, Mahendra ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

CNS; HIV 1; Monoamine neurotransmitters

Indexed keywords

EID: 38849143123     PISSN: 15536203     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajidsp.2007.177.183     Document Type: Article

References (46)

1. Resnick, L., J.R. Berger, P. Shapshak, W.W. Tourtellotte, 1988. Early penetration of the blood brain barrier by HIV. Neurology, 38: 9-14.
2. Persidsky, Y., M. Stins, D. Way, M.H. Witte, M. Weinand, K.S. Kim, P. Bock, H.E.Gendelman, M. Fiala, (1997. A model for monocyte migration through the blood brain barrier during HIV-1 encephalitis. J Immunolo. 158(7): 3499-3510.
3. Maslin, C.L.V., K. Kedzierska, N. Webseter, W. Muller, S. Crowe, 2005. Transendothelial migration of monocytes: the underlying molecular mechanisms and consequences of HIV-1 infection. Current HIV Research. 3(4): 303-317
4. Ho, D., T.R. Rota, R.T. Schooley, J.C. Kaplan, J.D. Allan, J. E. Groopman et al., 1985. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Eng J Med. 313: 1493-1497
5. Wiley, C.A., R.D. Shrie, J.A. Nelson, P.W. Lampert, M.B. Oldstone, 1986. Cellular localization of human immunodeficiency virus infection within the brains of acquired immunodeficiency syndrome patients. Proc Natl Acad Sci. 93: 7089-7093
6. Schrager, L.K., and M.P. D'Souza, 1998. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. JAMA. 280: 67-71
7. Navia, B.A., C.S. Cho, C.K. Petito, R.W. Price, 1986. The AIDS dementia complex. II. Neuropathology. Ann. Neurol. 19: 525-535
8. Price, R.W., B. Brew, J. Siditis, A. Rosenbaum, C. Scheck, P, Clearly, 1988. The brain and AIDS: central nervous system HIV infection and AIDS dementia complex. Science 239: 586
9. Brew, B.J., 1993. HIV-1 related neurological disease. J Acquired Immune Defic Syndrome. 6(suppl 1):S10-S15
10. Kieburtz, K., L. Ketonen, C. Cox, H. Grossman, R. Hoiloway, E.D. Caine, 1999. CNS as an HIV reservoir; BBB and drug delivery. Meeting Report, Arch Neurology. 53: 155-158.
11. Berger, J. R., M. Kumar, A. Kumar, J.B. Fernandez, B. Levine, 1994. Cerebrospinal fluid dopamine in HIV-1 infection. AIDS. 8:67-71.
12. Dursun, S.M., 1993. HIV infection, serotonin and sexual dysfunction. Br J Psychiatry. 162: 570-571.
13. Kumar, A.M., J.R. Berger., C. Eisdorfer, J.B. Fernandez, K. Goodkin, M. Kumar, 2001. Cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in HIV-1 infection. Neuropsychobiology. 44:13-18.
14. Wiley, C.A., V. Soontornniyomkij, L. Radhakrishnan, E. Masliah, J. Mellors, S.A. Herman, P. Dalley, C.L. Achim, 1998. Distribution of brain HIV load in AIDS. Brain Pathology. 8: 277-284.
15. Gaspar P, B. Berger, A. Febvret, A. Vigny, J.P. Henry, 1989. Catecholamines innervation of human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J of Comparative Neurology 279:249-271.
16. Previc, F.H., 1999. Dopamine and Origin of Human Intelligence. Brain & Cognition. 41:299-350.
17. Hriso, E., T. Kuhn, J. C. Masdeu, M. Grundman, 1991. Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy. Am J Psychiatry. 11:1558-1561.
18. Larsson, M., L. Hagberg, A. Forsman, G. Norkrans, 1991. Cerebrospinal fluid catecholamine metabolites in HIV-1 infected patients. J Neurosci Res. 28:406-409.
19. Atkinson, J.H., I. Grant, C.J. Kennedy, et al., 1988. Prevalence of psychiatric disorders among men infected with human immunodeficiency virus; a controlled study. Arch Gen Psychiatry. 45: 859-864.
20. Dursun, S.M., M.A. Reveley, 1995. Serotonin hypothesis of psychiatric disorders during HIV-1 infection. Med Hypotheses. 44:263-267.
21. Elliot, A. J., P.P. Roy-Byrne, 1998 Major depressive disorder and HIV-1 infection: A review of treatment trials. Semin Clin Neuropsychiatry 3: 137-150.
22. Ramsey, N., J. Catalan, B.Gazzard, 1992. Eating disorders in men with HIV infection. Br J Psychiatry. 160: 404-407.
23. McKegney, F.P., M.A. O'Dowd, 1992. Suicidality and HIV status. Am J Psychiatry. 149: 396-398.
24. Law, W. A., A. Martin, A.M.Salazar, R.L. Mapou, 1993. Symptoms of depression in HIV-infected individuals: Etiological considerations. Neuropsychiatry Neuropschol Behav Neuro. 6: 181-186.
25. Meltzer, H.Y., 1991. The significance of serotonin for neuropsychiatric disorders. J Clin Psychiatry. 52: 70-72.
26. Luciana, M., P. Collins, R. A. Depue, 1998. Opposing roles for dopamine and serotonin in the modulation of human spatial working memory function. Cerebral Cortex. 8: 218-226.
27. Navia, B. A., R. W. Price, 1987. The acquired immune deficiency syndrome dementia complex as the presenting or sole manifestation of human immune deficiency virus infection. Arch Neurol. 44: 65-69.
28. McArthur, J.C., D.R. Hoover, H. Bacellar, 1993. Dementia in AIDS patients: incidence and risk factors. Neurology. 43:2245-2252.
29. Masliah, E., C.L. Achim, N.Ge, R. DeTeresa, D. Terry, C.A. Wiley, 1992. Spectrum of HIV associated neocortical damage. Ann. Neurol. 32: 85-93.
30. Kumar, A.M., J. B. Fernandez, L. Gonzalez, M. Kumar, 2006. Ultramicro quantification of dopamine and homovanillic acid in human brain tissue: Quest for higher recovery and sensitivity with CoulArray HPLC-ECD system. J Liquid Chromatography & Related Technologies 29:1-23.
31. Kumar, A.M., I. Borodowsky, B. Fernandez, L. Gonzalez, M. Kumar. HIV-1 RNA load in different regions of human brain: Quantification using real time RT-PCR. J NeuroVirology (in press).
32. Kumar, A.M., M. Kumar, D. Krishnaprasad, J.B. Fernandez, C. Eisdorfer, 1990. A modified HPLC technique for simultaneous measurement of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in cerebrospinal fluid, platelet and plasma. Life Sci. 47: 1751-1759.
33. Sardar, A. M., C. Czudek, G.P. Reynolds. 1996. Dopamine deficits in the brain: The neurochemical basis of Parkinsonian symptoms in AIDS. Neuroreport. 7:910-912.
34. Bagasra, O., E. Levi, and L. Bobroski, 1996. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10: 573-585
35. Nuovo, G. J., F. Gallery, P. MacConnell, and A. Braun, 1994. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system. Am J Pathol. 144: 659-666.
36. Ensoli, F., H. Wang., V. Morelli, S. L. Zeichner, M. R. Cristofero De, G. Luzi, C.J.Thiele, 1997. HIV-1 infection and the developing nervous system: lineage-specific regulation of viral gene expression and replication in distinct neurenal precursors. J Neurovirolo. 3(4), 290-298.
37. Bennet, B.A., D.E. Rusyniak, C.K. Hollingsworth, 1995. HITV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. Brain Res. 705:168-176.
38. Nath, A., 2002. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. The Journal of Infectious Diseases 186(suppl 2): S193-198.
39. Nath, A., C. Anderson, M. Jones, W. Maragos, R. Booze, C. Mactutus, J. Bell, K. F. Hauser, M Mattson, 2000. J Psychopharmacology. 14(3):222-227.
40. Zauli, G., P. Secchiero, R. Luigi, D Gibellini, P. Mirandola, M. Mazzoni, M. D. Milani, D.R. Dowd, S. Capitani, M. Vitale, 2000. HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells. The J of Biological Chemistry 275:4159-4165.
41. Ellis, R., M.E. Childers, A.M. Kumar, M. Kumar, T. Goetz, M. Caligiuri, 2004. Decreased cerebrospinal fluid dopamine correlates with impaired motor skills in HIV-1 infection and methamphetamine dependence. Society for Neurosciene, 34th Annual Meeting, SanDiego, Oct 23-27
42. Heyes, M.P., K. Saito, and S.P. Markey, 1992. Human macrophages convert L-tryptophan in to the neurotoxin quinolininc acid. Biochem J. 283:633-635.
43. Heyes, M. P., K. Saito, A. Lackner, C.A Wiley, C.L. Achim, S.P. Markey, 1998. Sources of the neurotoxin quinolinic acid in the brain of HIV-1 infected patients and retrovirus-infected macaques. The FASEB. 12: 881-896.
44. Nath, A., J. D.Geiger, 1998. Neurobiological aspects of HIV infection: Neurotoxic Mechanisms. Prog Neurobiol. 54:19-33.
45. Kumar, M., R. Morgan, J. Szapocznik, C. Eisdorfer, 1991. Norepinephrine response in early HIV infection. J Acquir Immune Defic Syndr. 4:782-786
46. Kumar, M., A. M. Kumar, D. Waldrop, M.H. Antoni, N. Schneiderman, C. Eisdorfer, 2002. The HPA axis in HIV-1 infection. JAIDS. 31:S89-S93.